Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +1.09% |
|
+14.20% | -87.43% |
06-24 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.43% | 124M | |
+2.95% | 93.98B | |
-3.42% | 37.69B | |
-13.75% | 32.99B | |
+73.19% | 28.27B | |
-11.88% | 16.17B | |
+0.49% | 14.33B | |
-12.95% | 11.44B | |
+190.36% | 10.96B | |
-54.07% | 9.26B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Transcript : Amylyx Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08